XML 33 R26.htm IDEA: XBRL DOCUMENT v3.26.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activity The following table summarizes the Company’s stock option activity for the three months ended March 31, 2026:

 

 

Number of
Shares

 

 

Weighted-
Average
Exercise
Price per
share

 

 

Weighted-
Average
Remaining
Contractual
Term
(in years)

 

 

Aggregate
Intrinsic
Value
(in thousands)

 

Balance at December 31, 2025

 

 

6,287,477

 

 

$

12.23

 

 

 

8.62

 

 

$

113,839

 

Granted

 

 

1,937,970

 

 

 

27.76

 

 

 

 

 

 

Exercised

 

 

(80,867

)

 

 

10.01

 

 

 

 

 

 

 

Forfeited

 

 

(117,166

)

 

 

21.86

 

 

 

 

 

 

 

Options outstanding at March 31, 2026

 

 

8,027,414

 

 

$

15.86

 

 

 

8.69

 

 

$

123,835

 

Options vested and exercisable at March 31, 2026

 

 

2,464,603

 

 

 

11.03

 

 

 

8.12

 

 

 

49,941

 

Options vested and expected to vest at March 31, 2026

 

 

8,027,414

 

 

$

15.86

 

 

 

8.69

 

 

$

123,835

 

 

Summary of Restricted Stock Awards Grant Activity

The following table summarizes the Company’s service-based RSA grant activity for the three months ended March 31, 2026:

 

 

RSAs

 

 

Weighted-
Average Grant
Date Fair Value

 

Unvested shares at December 31, 2025

 

 

411,833

 

 

$

3.94

 

Granted

 

 

 

 

 

 

Vested

 

 

(87,574

)

 

 

3.84

 

Forfeited

 

 

(28,846

)

 

 

2.92

 

Unvested shares at March 31, 2026

 

 

295,413

 

 

$

4.06

 

Summary of Performance-based RSA Grant Activity

The following table summarizes the Company’s performance-based RSA grant activity for the three months ended March 31, 2026:

 

 

RSAs

 

 

Weighted-
Average Grant
Date Fair Value

 

Unvested shares at December 31, 2025

 

 

212,977

 

 

$

3.72

 

Granted

 

 

 

 

 

 

Vested

 

 

(44,591

)

 

 

3.74

 

Forfeited

 

 

(24,129

)

 

 

2.92

 

Unvested shares at March 31, 2026

 

 

144,257

 

 

$

3.85

 

Summary of Share-based Compensation Expense The following table below summarizes the classification of the Company’s stock-based compensation expense related to stock options and restricted common stock awards in the condensed consolidated statements of operations and comprehensive loss (in thousands):

 

 

For the Three Months
Ended March 31,

 

 

2026

 

 

2025

 

General and Administrative

 

$

4,169

 

 

$

2,719

 

Research and Development

 

 

2,794

 

 

 

1,321

 

 

$

6,963

 

 

$

4,040